Brought to you by 
Sinovac scooped up by consortium and becomes private
08 Feb 2018
Executive Summary
Vaccines developer Sinovac Biotech Ltd. is being acquired by a consortium consisting of the company's president and CEO Yin, SAIF, C-Bridge Capital, Advantech Capital, and Vivo Capital.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com